Viret Jean-Frederic 4
4 · Coherus BioSciences, Inc. · Filed Jan 27, 2021
Insider Transaction Report
Form 4
Viret Jean-Frederic
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-01-25$20.10/sh−40,000$804,000→ 67,439 total - Exercise/Conversion
Common Stock
2021-01-25$10.05/sh+40,000$402,000→ 107,439 total - Sale
Common Stock
2021-01-25$19.00/sh−6,144$116,736→ 61,295 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-01-25−40,000→ 61,569 totalExercise: $10.05Exp: 2028-02-01→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person.
- [F2]Includes 52,083 restricted stock units.
- [F3]The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.